| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 96,121 | 96,009 | 97,143 | 101,322 | | Cost of Revenue | 66,106 | 64,810 | 71,500 | 70,407 | | | Gross Profit | 30,015 | 31,199 | 25,643 | 30,915 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
|
-
|
-
| | Non Recurring | 19 | 450 | 29,628 | 4 | | Others | 15,175 | 20,885 | 19,611 | 18,790 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,821 | 9,864 | (23,596) | 12,121 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (25) | (11) | 89 | 201 | | Earnings Before Interest And Taxes | 14,796 | 9,853 | (23,507) | 12,322 | | Interest Expense | 10,302 | 8,340 | 8,468 | 8,548 | | Income Before Tax | 4,494 | 1,513 | (31,975) | 3,774 | | Income Tax Expense | 1,961 | 669 | (13,108) | 1,730 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,533 | 844 | (18,867) | 2,044 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,533 | 844 | (18,867) | 2,044 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,533 | $844 | ($18,867) | $2,044 |
|
0.22% Nasdaq 
Income Statement
